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Head/Director's Message
David H. Zeman, DVM, PhD

High Containment Facility Needs of the ADRDL: an update
As your Director of the SD Animal Disease Research
and Diagnostic Laboratory (ADRDL), I have spoken to you
in recent years about significant national and international
trends that are impacting the way state animal health
laboratories conduct business. A variety of rising risk factors
have increased the likelihood that state animal health
laboratories will be significantly involved with animal
disease outbreaks of high consequence, many of which are
also human diseases. Some of these outbreaks may be
accidental introductions of dangerous diseases into our
service region, while others may be malicious introductions
of foreign or manipulated pathogens. The following rising
risk factors and synergistic opportunities seem to make this
the ideal time to seriously assess our situation:
• Rising Risks due to Globalization of Animal
Agriculture
• Rising Risks due to Agroterrorism
• Rising Risks due to Changing Societal Expectations
o The environment and EPA regulations
o Public/Community health and agricultural
hazard control
o Employee health hazards

Diagnostic News

•
•
•

Synergism with the VSD, ABS College and SDSU
Research Programs
Synergism with State and Local High-Technology
Economic Development
Synergism with Federal/State Diagnostic Networks
(NAHLN, FERN, LRN)

In response to these trends, many state animal health
laboratories have already built high containment facilities
(BSL3) to handle pathogens of high consequence and of
zoonotic concern. Currently the ADRDL has no high
containment diagnostic or research space. A stakeholder
committee has been formed by animal industry stakeholders
to study and find solutions to this issue for South Dakota.
Co-chairs of the committee are Christine Hamilton
(Christianson Land and Cattle Company) and Dr. Dan
Farrington (retired DVM industrial researcher). They will
work with key representatives of all friends of animal health
in the state, to keep the ADRDL on the cutting edge of the
ever-changing disciplines of diagnostic medicine and disease
research.

- SDSU ADRDL

Classical Swine Fever
Surveillance (Hog Cholera) at
the SDSU ADRDL:
The ADRDL has recently obtained a $75,000
cooperative agreement grant from the USDA to conduct
Classical Swine Fever (CSF) surveillance. This disease, also
known as Hog Cholera, is of high interest to the US swine
industry. The program is coordinated by the National Animal
Health Lab Network (NAHLN). ADRDL diagnosticians
have been asked to test tissues from as many sick or dead
pigs as possible, as they are submitted to the diagnostic

laboratory for other routine disease investigations. There will
be no charge to our clients for this passive surveillance
activity.
To encourage testing activity, practitioners will receive
a financial reward for their efforts. For any routine disease
investigation a $50 credit per pig (up to 3 pigs per case;
cannot exceed maximum bill for the case) can be applied to
that diagnostic bill if appropriate specimens for CSF testing
are included with your submission. Appropriate specimens
to qualify for the credit are:
• Any age sick or dead pig from any of our clients
(not restricted to SD clients)
• Must submit dead pigs with tonsils or collect and
submit a fresh tonsil during an on farm necropsy

Animal Health Matters
This is a tremendous opportunity to participate in an
important surveillance activity and receive free diagnostic
support at the same time. In most cases, the credit will cover
all or at least most of the diagnostic investigation expenses
for any of your routine morbidity and mortality investigations
such as scours, pneumonia, CNS, or sudden death syndromes.
We look forward to receiving fresh tonsils with your
submissions and dead pigs submitted to the ADRDL. The
program will continue until December 31, 2007 or until funds
are depleted.
Questions: Call Dr. David Zeman at 605-688-5172 or
email at David.Zeman@sdstate.edu

assigned to one team member, with challenging cases
reviewed by all. Team members are Dr. David Zeman, Dr.
Tanya Graham, and Dr. David Knudsen.
David Zeman DVM, PhD, DACVP is a veterinary
graduate of Oklahoma State University and PhD graduate of
Louisiana State University, where he also completed his
veterinary pathology residency. He joined the ADRDL in
1986, and is now laboratory director. He was designated
South Dakota veterinarian of the year in 2003 by the
SDVMA, and laboratory diagnostician of the year in 2006 by
the American Association of Veterinary Laboratory
Diagnosticians (AAVLD). He particularly enjoys infectious
disease investigations and tumor biopsies.
Tanya Graham DVM, DACVP graduated from
Oklahoma State University in 1994, then completed her
residency in veterinary pathology at Texas A&M and then
joined the pathology faculty at OSU. She then worked as a
diagnostic pathologist at the University of Pennsylvania for
two years, and moved to the ADRDL in 2000. She is
associate director of the laboratory, and section head of
Histopathology and Immunohistochemistry. Currently, her
interests beyond routine diagnostic pathology include avian
pathology and regulatory diagnostic medicine.
David Knudsen DVM, MS, DACLAM is a 1982
graduate of Colorado State University and was in mixed
animal practice for three years before completing residencies
in veterinary pathology and laboratory animal medicine at
University of Missouri – Columbia. After five years on staff
at University of California – Davis, he was a private
consultant in veterinary and comparative pathology for
pharmaceutical and biotechnology companies before joining
the ADRDL in 2002 as a diagnostic pathologist and section
head for Clinical Pathology.
As in the past, a typical biopsy case accession includes
processing and examination of up to 3 masses or samples
from the same patient, up to 2 special stains as needed,
written report plus phone consultation as needed, and return
of the shipping container with fresh formalin, for a single
case charge of $20 plus a $8 case generation fee. There is no
additional charge for decalcification, but an additional day for
processing is generally required. Biopsy shipping containers,
which include a small jar of formalin and a slide mailer for
cytologic samples, are available for a nominal initial fee.

Biopsy Service Changes at the
ADRDL – Effective July 1, 2007

As part of our ongoing efforts to optimize diagnostic
services at the ADRDL, we have instituted some changes to
the Biopsy Service which will take effect on July 1.
The most important change is that lab schedules have
been modified to ensure that a written diagnostic report
will be faxed to the submitter within 24 hours of our
receipt of the sample. This report will include a
morphologic diagnosis, or at least our initial impression of
the lesion pending additional stains, and additional
interpretation as indicated. After the case is finalized, we are
also available for phone consultation during regular business
hours at no additional charge.
Another change is that a team of veterinary pathologists
will rotate through the service, giving a high priority to
expertise and shortened turn-around time. Each case will be

Listing of Pharmacies Offering
Compounding Services for
Veterinarians – April 2007
Compiled by Regg Neiger, DVM PhD

Holiday hours:

Animal Pharmacy
66 West Avenue
Canandaigua, NY 14424
Phone: (800) 663-5261
Local Phone: (585) 394-4930
Fax: (585) 396-7264

September 3 – Labor Day
October 8 – Native American Day
November 12 – Veteran’s Day Observance
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Island Pharmacy Services, Inc.,
P.O. Box 1412
Woodruff, WI 54568
Phone: (800) 328-7060
Fax: (715) 358-7021

Pine Pharmacy
5110 Main Street
Williamsville, NY
Local Phone: (716) 332-2288
Fax: (716) 332-2287

Pet Health Pharmacy, Inc.
12012 N. 111th Avenue
Youngtown, AZ 85363
Phone: (800) 742-0516
Local Phone: (623) 214-2791
Fax: (866) 373-0030

Shiner Family Pharmacy
Carolyn Hilscher, Pharmacist/Owner
P.O. Box 666
408 N Avenue B
Shiner, TX 77984
Phone: (361) 594-2394

Pine Pharmacy
1806 Pine Ave.
Niagara Falls, NY
Phone: (800) 355-1112
Local Phone: (716) 282-1112
Fax: (716) 282-0654

Valley Drug and Compounding, Inc.
16928 Ventura Blvd.
Encino, CA 91316
Phone: (877) 482-6231
Local Phone: (818) 788-0635
Fax: (818) 386-2688

Specialty Pharmacy Services, Inc
800 E. Melbourne Ave.
Melbourne, FL 32901
Phone: (800) 499-7517
Local Phone: (321) 953-2004
Fax: (800) 784-3128
Local Fax: (321) 953-2808

Red Cross Drug
Box 2090
Blanchard, OK 73010
Phone: (800) 759-6963
Local Phone: (405) 485-9311
Fax: (405) 485-9312

Research News

- SDSU Veterinary Science Department
that is the first in a new class of anti-HIV drugs called
"maturation inhibitors." Li said the drug interferes with virus
particles called "virions" by not allowing the core of the
virion to assume its mature conical shape.
Some researchers say virions can be compared to
spacecraft in that they transport the genome of the virus from
cell to cell and protect it in inhospitable environments. The
new drug attacks HIV by disabling the virions -- it leaves
them too immature and imperfectly formed to infect another
host cell, and so the infection dies. Importantly, Li said, the
drug may help deal with the issue of drug resistance, the
leading reason that treatments fail for HIV patients.
"We do have the situation where, whenever people get
infected with HIV, that transmitted HIV strain likely already
has developed resistance to approved drugs. The new
inhibitor we are working on could really provide a new
option for treatment in overcoming resistance," Li said. "This
inhibitor is different from all the other approved drugs."
Hardwidge said the goal of the two-year SDSU study is
to characterize as precisely as possible what the drug does
and also to examine viral resistance as it relates to the drug.
"We have a novel compound, but at a molecular level,
how this compound functions is not absolutely clear yet. If

CIDRV Research Looks at
New HIV Drug
Researchers with the SDSU Center for Infectious
Disease Research and Vaccinology (CIDRV) have won a
major grant to study a new drug for treating HIV.
The National Institutes of Health has awarded $389,000
to help SDSU scientists research the mechanism of action of
a drug called bevirimat. A company called Panacos
Pharmaceuticals Inc. makes the drug.
HIV, or human immunodeficiency virus, is a virus that
causes acquired immunodeficiency syndrome, or AIDS, in
humans. The immune system begins to fail in patients with
AIDS, leaving them vulnerable to life-threatening infections.
The Joint United Nations Programme on HIV/AIDS and the
World Health Organization estimated that about 39.5 million
people were living with AIDS at the end of 2006.
Principal investigator Feng Li, an associate professor
with the CIDRV, said there are already three classes of drugs
being used to treat HIV. Li and his co-investigator, SDSU
assistant professor Philip Hardwidge, will study a compound
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masters degrees in Entomology and Microbiology, and a PhD
in Veterinary Microbiology from SDSU.
Dr. Fang’s research has focused on the molecular
characterization of porcine reproductive and respiratory
syndrome virus (PRRSV) and applying that knowledge in the
development and evaluation of vaccines and diagnostic
assays for PRRSV. The laboratory has successfully
constructed a full-length cDNA (complementary DNA)
infectious clone of European-like Type 1 PRRSV that
recently emerged in the US. Current efforts are directed
towards the use of this reverse genetics system to study
PRRSV pathogenesis and develop the next generation of
genetically engineered PRRSV vaccines.
As a member of the SDSU Hybridoma Facility, she is
directing the establishment of a panel of monoclonal
antibodies against PRRSV non-structural proteins. A
collaborative project also involves developing monoclonal
antibodies against Severe Acute Respiratory Syndrome
(SARS-CoV) nucleocapsid protein, and the study of the basic
mechanism of nucleocapsid protein function in the
pathogenesis of SARS.
Dr. Fang’s current projects include:
1. Genetic marker development in the Nsp2 region of
a European-like PRRSV: Implication for future
recombinant marker vaccine development. PRRS
continues to plague the pork industry worldwide. To control
this disease, there is a great need for new generations of
PRRS vaccines. One of the key steps in development of
these new vaccines would be to include markers for
diagnostic differentiation of vaccinated animals from those
naturally infected with wild-type virus. Such vaccines would
greatly benefit PRRSV elimination, since it would be
possible to assess the effectiveness of MLV vaccines. In this
project, a full-length cDNA infectious clone of a Europeanlike PRRSV isolate was constructed as a viral backbone.
Then a marker was inserted into the unique deletion site of
the Nsp2 region of the infectious clone as a means to identify
vaccinated animals using routine serology. In the third step,
conserved epitopes in the Nsp2 region were deleted so that
the immune response to a wild-type virus could be detected in
vaccinated pigs.
2. In vivo evaluation of genetic markers in the Nsp2
region of PRRSV: Implications for future recombinant
marker vaccine development. Two Nsp2 mutant viruses
have recently been constructed. Previous work resulted in the
development of Nsp2 epitope-based differential ELISA
assays. The goal of this study is to observe how these Nsp2
marker viruses behave in the live animal, and to study the
potential of using the Nsp2-specific ELISAs to identify and
differentiate vaccinated animals from naturally infected
animals.
3. Accurate ELISA test development for PRRSV
serology: Evaluation of cysteine protease domains of Nsp2
as potential diagnostic targets. The overall goal of this
study is to characterize the PRRSV cysteine protease (CP)
domain and the conserved epitope of Nsp2 along with the
serological response to these antigens.

we understand that better, we may be able to improve the
efficacy of the drug, we may be able to modify it so that HIV
is less prone to evolve resistance against it," Hardwidge said.
"With all of these compounds it's crucial to understand
precisely how they're acting in order to make them the best
drugs they can be."
Li said unlike other drugs, bevirimat does not attack the
HIV viral enzymes, which may undergo modification readily
as new strains of the virus develop. Instead, it will attack a
part of the virus structure protein that is highly conserved
among different viral strains.
That approach gives doctors a new tool to treat drugresistant strains of HIV, and it also suggests the new
compound may remain effective longer in the fight against
HIV.
David Zeman, head of SDSU's Department of Veterinary
Science, said the new grant is one example of how the
governor's 2010 Centers of Excellence are beginning to
produce results for South Dakota. Both Feng Li and Philip
Hardwidge were recruited about two years ago to fill
positions in the Center for Infectious Disease Research and
Vaccinology. Both scientists maintain positions in both the
SDSU Department of Veterinary Science and the SDSU
Department of Biology/Microbiology.
The center fosters research leading to the development of
novel therapeutic and diagnostic technologies and products
for infectious diseases in humans and domestic animals.
Hardwidge added that the project illustrates one way that
SDSU is looking beyond its borders to address major issues
important to science.
"We're pleased with the federal funding for this project
and we appreciate SDSU's support for basic biomedical
research," Hardwidge said.
Sources: SDSU AgBio Communications, Yankton Press and
Dakotan

Research Spotlight:
Dr. Ying Fang
Dr. Ying
Fang joined the
faculty of the
SDSU Veterinary
Science
Department and
the Center for
Infectious
Disease Research
and Vaccinology
in 2005. She
holds a
bachelor’s degree
in Biology,
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The cysteine protease domain (CP) of PRRSV Nsp2 was
evaluated as a potential new antigen for sensitive, specific
and differential diagnostic ELISA tests. Antibody to the CP
domain could be detected as early as 14 dpi, and the CPbased ELISA detected the antibody response to diverse field
strains.
4. Production of monoclonal antibodies against the
PRRSV non-structural proteins. In order to produce new,
safe, and effective vaccines and antiviral drugs against PRRS,
a thorough understanding of the basic biology of the virus is
needed. Since PRRS research began, a great deal of
knowledge has been revealed about PRRSV’s structural
proteins, but very little is known about PRRSV’s nonstructural proteins (Nsps). NSPs play roles in mediating
replication and transcription of the structural proteins of the
virus. This makes them attractive targets for the development
of antiviral drugs. One of the key reagents to study protein
structure-function and design antiviral intervention strategies
is the monoclonal antibody (mAb). Since the first
development of mAbs thirty years ago, thousands of
bioscience researchers worldwide rely on them to understand
the structures, functions, and interactions of complex
biomolecules. MAbs also contribute tremendously to in vitro
diagnostic tests and in vivo therapeutic uses in clinical
medicine. Previous work has built up a large panel of mAbs
against PRRSV structural proteins, but no mAbs have been
made against PRRSV Nsps. Therefore, the aim of this work
is generating a full panel of mAbs against all Nsps of Type 1
and Type 2 PRRSV. This project will provide basic key
reagents for study of the fundamental biology of PRRSV
Nsps. The proteins and mAbs produced will be good
candidates for future development of diagnostic assays.
5. The Role of PRRSV Nonstructural Protein 2 in
Viral Replication. This is another study that looks at nonstructural proteins (Nsps) in PRRSV. As previously
mentioned, NSPs play roles in viral replication. In particular,
NSP2 has been shown to encode a putative cysteine protease,
and in cell culture, it’s been shown that a cysteine protease
inhibitor can block viral replication. In addition, Nsp2 is a
very immunogenic protein that induces an earlier immune
response than that of PRRSV structural proteins, suggesting
that Nsp2 may be involved in the modulation of host
immunity. This makes it attractive for development of
antiviral drugs and vaccines. This study will focus on

Extension News

elucidating the basic properties of Nsp2 in viral replication.
From this research, a cell-free model system for the study of
PRRSV Nsps will be created, which can be used for high
throughput screening of anti-PRRSV drugs. Better
characterization of Nsp2 will allow the design and
development of antiviral drugs, which directly target the virus
and do not depend on the host immunity. These would be
extremely valuable as a means to protect certain genetic
breeding herds and seed stock herds, such as boar studs. In
addition, altering Nsp2 function in PRRS viruses may be a
means for production of attenuated vaccine viruses.
6. The role of PRRSV non-structural protein 1 and
2 in host immunity. The overall goal of this project is to
understand the basic functions of PRRSV Nsp1 and Nsp2 in
viral pathogenesis and host immunity. PRRSV infection
typically induces a rapid, robust host humoral antibody
response that is comprised predominantly of non-neutralizing
antibodies. In contrast, anti-viral innate and cell mediate
immune responses initially remain at a fairly low level. When
anti-PRRSV neutralizing antibodies do appear, the response
is slow and titers remain low. Many pathogens, in order to
evade the immune system, will initially present nonprotective but immunodominant epitopes to the host immune
system, which decoy or dysregulate the ability of the immune
system to focus on more protective targets, and subsequently,
suppress a more protective immune response, resulting in
semiprotective immunity.
Recent studies from Dr. Fang’s laboratory revealed that
swine mount an immediate non-neutralizing antibody
response to Nsp1 and Nsp2. The antibody response to Nsp1
and Nsp2 is greater than that to any other PRRSV protein,
and lasts more than 120 days, which indicates the
immunodominant nature of these proteins. This strong,
immediate non-neutralizing humoral response induced by
Nsp1 and Nsp2 suggests that these proteins may be involved
in modulation of the host immune system. Therefore, in this
proposed study, it is hypothesized that PRRSV Nsp1 and
Nsp2 function as immune modulators to decoy the ability of
the immune system to focus on more protective targets. This
study will provide basic knowledge for future development of
more effective and broadly protective second-generation
PRRSV vaccines.

- SDSU ADRDL
the U.S. livestock, poultry, and aquaculture populations.
These studies are designed to meet the information needs of
the industries and other stakeholders – as identified by people
working with these industries.
In 1993, NAHMS conducted the Cow/Calf Health and
Productivity Audit (CHAPA). CHAPA provided baseline
information on U.S. beef cattle inventories, health and
management practices, forage nutrient content, and animal

National Animal Health
Monitoring System (NAHMS) to
Study Beef Industry in 2007-08
The U.S. Department of Agriculture’s (USDA) NAHMS
conducts national studies on the health and management of
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selenium deficiency status. The Beef ’97 study built on the
results of CHAPA. Objectives of the Beef ’97 study included
describing trends in health issues affecting the U.S. beef herd
and acquiring national prevalence estimates of
Mycobacterium paratuberculosis (Johne’s disease) exposure
and infections with bovine leukosis virus.

Testing Options
Results from tests on biological samples will be provided
to participating producers at the conclusion of the study.
BVD Virus
Goal: Estimate the percentage of calves persistently
infected with BVD virus by testing ear notch samples. The
study will also help to identify factors associated with herds
having persistently infected calves.
Food-Safety Pathogens
Goal: Estimate the prevalence of specific food-safety
pathogens such as Salmonella and E. coli O157 via testing of
fecal samples.
Confidentiality
Because NAHMS’ studies rely on voluntary
participation, APHIS protects the privacy of every
participant. Only those collecting the data know the identity
of the respondent. No name or address is ever recorded in
any APHIS database. No data will be reported on any
individual or in a manner that would allow the identification
of an individual.

NAHMS Beef 2007-08 Study
The NAHMS Beef 2007-08 Study will continue to
address the priority issues of the U.S. beef cattle industry and
other stakeholders. Twenty-four States will participate in
Beef 2007-08. These states represent 79.4 percent of U.S.
beef herds and 87.8 percent of U.S. beef cows. The Beef
2007-08 Study will:
• Describe trends in beef cow-calf health and
management practices,
• Evaluate management factors related to beef quality
assurance,
• Describe record-keeping practices on cow-calf
operations,
• Determine producer awareness of bovine viral
diarrhea (BVD) virus and management practices
used for BVD control,
• Describe current biosecurity practices and producer
motivation for implementing or not implementing
biosecurity practices and,
• Determine the prevalence and antimicrobial
resistance patterns of potential food-safety
pathogens.

Pieces and Parts
•

By gathering reliable and valuable information on the
U.S. beef cattle industry, the Beef 2007-08 Study will help to
• Educate the producers and practitioners of tomorrow
• Help policymakers and industry make informed
decisions,
• Measure the impact of disease,
• Evaluate the potential impact of diseases affecting
beef cattle and/or human health,
• Assist researchers and private enterprise to identify
and focus on vital issues related to beef cattle health
and productivity, and
• Conduct economic analyses of the health and
production of the U.S. beef industry.
Participation in all NAHMS studies is voluntary.
Randomly selected producers will be contacted by
representatives from USDA’s National Agricultural Statistics
Service from October through November, 2007. An on-site
questionnaire will be administered, and eligible producers
will be asked to participate in the second phase of the study.
Producers that choose to continue in the study will be visited
by veterinary medical officers (VMOs) and/or animal health
technicians (AHTs) who will administer questionnaires and
collect biological samples from January through March,
2008. VMOs and/or AHTs will make a second contact from
July through August, 2008.

Extension Publication Spotlight:
1. Raising Cattle “Naturally”: The Significance of
Animal Health (ExEx 11020). “Naturally raised”
cattle programs generally prohibit the use of
antibiotics, ionophores, and growth promotants.
This publication outlines some of the more
common health ailments encountered in raising
cattle for the natural market, along with
management recommendations to minimize these
problems when the usual medications used for
prevention or treatment may not be available to be
used.
2. How to Capture High Calf Prices (ExEx 5055).
Producers in South Dakota market a high
proportion of the state’s calf crop shortly after
weaning. Generally, the largest volume of sales
occurs during October and November with the
calves commonly weighing 500–600 lb. This
publication provides suggestions for producers
who will be selling calves on how to capture the
relatively high prices currently available.
3. Livestock Risk Protection: Insuring Calves (ExEx
5058). Historically high cash prices for calves,
general price volatility, and concern that prices
could move lower may lead producers to insure
calf prices. Livestock Risk Protection (LRP) is an
insurance program that covers a single peril: lower
prices. This publication explains how LRP works
and outlines considerations for its use.

These publications, among many others, are
available for free at: http://agbiopubs.sdstate.edu.
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researchers as we grow our research program to
maximize service to our stakeholders.” The VSD
Research Coordinator's role is to work closely with the
department head and faculty on management and
strategic issues relative to the department’s research
program. In this role, Dr. Young replaces Dr. David
Francis, who will focus on his responsibilities with the
Center for Infectious Disease Research and
Vaccinology.

Dr. Young Named Research Coordinator for
Veterinary Science Department. Dr. Alan Young
has been named Research Coordinator for the SDSU
Department of Veterinary Science. In making the
announcement, Dr. David Zeman, Veterinary Science
Department Head, said, “Dr. Young is an excellent
team player and a natural leader, who brings forth
positive constructive ideas to an issue. I look forward
to working with him and all of the department

Student News

- SDSU Veterinary Science Department
Christine Ferderer, Baltic, SD – Kansas State University
Nathan Runke, Willmar, MN – University of Minnesota
Loni Schumacher, Eureka, SD – Oklahoma State
University
Kim Wellendorf, Ida Grove, IA – Iowa State University

SDSU Pre-Veterinary Students
Accepted to Veterinary Schools
Four South Dakota State University pre-veterinary
students have been accepted to veterinary schools for Fall
2007:

Congratulations and good luck to these students as they
embark upon their professional education.

Calendar of Events
September 13-14, 2007
Iowa Veterinary Medical Association Annual Meeting
Scheman Center, Ames, IA
http://www.iowavma.org/

August 12-15, 2007
South Dakota Veterinary Medical Association Annual
Meeting
Ramkota Inn, Sioux Falls, SD
Large and small animal sessions: Future of the ethanol
industry/use of co-products; drug use and the VCPR in
dairies and beef herds; latest on Johne’s disease; food animal
diagnostics; companion animal emergency care, orthopedics;
SDSU case reports, much more.
605-688-6649 or www.sdvetmed.org

September 15-18, 2007
Allen D. Leman Swine Conference
RiverCentre, St. Paul, Minnesota
http://www.cvm.umn.edu/outreach
September 15-18, 2007
Central Veterinary Conference
Bartle Hall, Kansas City, MO
http://www.thecvc.com

August 1-3, 2007
North Dakota Veterinary Medical Association Annual
Meeting
Doublewood Inn, Bismarck, ND
http://www.ndvma.com

September 20-22, 2007
American Association of Bovine Practitioners
Vancouver Convention & Exhibition Centre, Vancouver,
BC
http://www.aabp.org/meeting/default.asp

August 2-4, 2007
Academy of Veterinary Consultants Summer Meeting
Embassy Suites Hotel, Kansas City, MO
http://www.avc-beef.org/
August 16, 2007
George A. Young Swine Health and Management
Conference
Marina Inn, South Sioux City, NE.
http://georgeyoungswineconference.unl.edu/
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Editor: Russ Daly, DVM

The SDSU Veterinary Science Department conducts
research, teaching, professional service, and extension service
to South Dakota and the surrounding region. Entities within the
department include the South Dakota Animal Disease Research
and Diagnostic Laboratory, the Olson Biochemistry Laboratory,
and the Center for Infectious Disease Research and
Vaccinology.
The South Dakota Animal Disease Research and
Diagnostic Laboratory is a full-service, all-species diagnostic
laboratory accredited by the American Association of Veterinary
Laboratory Diagnosticians (AAVLD). The AAVLD accreditation
program complies with international expectations for quality
diagnostic services under the guidance of the World Organization
for Animal Health (the OIE). The ADRDL collaborates with the
USDA National Veterinary Services Laboratory on many federal
disease monitor and eradication programs and is a member of
the National Animal Health Laboratory Network. For information
regarding the laboratory’s Quality System, contact Rajesh
Parmar – ADRDL Quality Manager, at 605 688 4309.
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